Exome sequencing identifies homozygous MDGA2 loss-of-function variants in nine individuals and functional neuronal assays show impaired MDGA2 trafficking with disrupted Nlgn1-dependent excitatory synapse regulation causing DEE.
0:00Welcome to Base by Base, the paper cast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. I want to start today with, um, a bit of a mechanical problem.
0:12I want you to picture a high performance sports car. It's sitting at the very top of a steep hill. This thing is just built for speed, massive engine, perfect aerodynamics, the whole deal. You take your foot off the brake, gravity takes over, and the car starts to roll.
0:27And naturally, it's going to accelerate. That's just physics. Right. It's picking up speed faster and faster. The engine roars, adding even more power. You are flying. The wind is just screaming past and right as you hit top speed.
0:41You see a curve coming up. Time to slow down. You reach for the brake pedal, and your foot just hits the floor. It's not broken, it's gone. It was never even installed. That is a terrifying image. I mean, without that break.
0:53The car's greatest asset, its speed becomes its own destruction. The whole machine just tears itself apart. And that exact moment, that realization that the mechanism to stop is missing, is the core metaphor for the paper we're diving into today.
1:08Because we're not talking about cars. We're talking about the human brain. We're talking about what happens when the genetic instruction for the braking system goes missing before a child is even born.
1:18It's a really profound analogy. We tend to think of the brain as, you know, a computer, but biologically, it's much more like an engine that needs this constant delicate balance. You mean excitation and inhibition.
1:34Exactly. The E over eye balance. Excitation is a gas pedal and inhibition is the brakes. So excitation is thinking moving all the ghost signals. That's all, the ghost signals, but you absolutely need innovation to shape those signals, to stop them from just spreading chaotically everywhere.
1:50When you lose the brakes, you don't just get a brain that works faster. You get a brain that is completely overwhelmed by its own connectivity, a system in total overdrive. And the paper we have today, published just recently on February 5th, 2026 in the American Journal of Human Genetics, finally puts a name to this failure.
2:07It identifies a specific gene, MDGA2, as that missing break. It's a major piece of work. The title is MDGA2, homozygis, loss of function variants, cause developmental and epileptic encephalopathy. And before we get into the heavy science, we really have to acknowledge the massive team behind this.
2:26People like Hiba Morsi, Hyano Kim, Cuban Jang, and all their colleagues. Looking at the affiliations, this was a truly global effort. You've got the UCL Institute of Neurology in the UK, DGIST in Korea, plus centers in Egypt, Saudi Arabia.
2:41It's a global dragnet. Yeah. Has to be. Red disease research is a numbers game. You have to cast an incredibly wide net to find enough patience to prove that one specific gene is the culprit. So let's set the scene.
2:52The problem they were tackling is something called DE's. Developmental and epileptic encephalopathies. Now we've covered epilepsy before, but DE's are a whole different category. much more severe. What's the key difference?
3:02The key word is encephalopathy. It implies that the epileptic activity itself is contributing to severe cognitive and behavioral problems. So it's more than just the underlying cause of the seizures. It's a double hip.
3:16The seizures themselves are making things worse. You get these early onset, intractable seizures, meaning standard drugs don't really work, and at the same time, you see developmental stagnation. Or even regression.
3:28It's that classic diagnostic odyssey. Parents watching their baby Cs, going from specialist to specialist, getting no answers. They know what is happening, but they have no idea why. Exactly. And that's why finding MDGA 2 is such a breakthrough.
3:42The thing is, we've known about this gene for a while, at least in the lab. Oh, really? Yeah. We know it's on chromosome 14. And we know from mouse models that if you delete it, if you knock it out completely, what happens?
3:52It's lethal. Lethal. Yes. The mice barely survive birth. Wow. So that's a huge red flag right there. It tells you the gene isn't just some minor player. No, it's load bearing infrastructure. You take it out, the whole building collapses.
4:05But there was this frustrating gap. We knew it was essential in mice, but we'd never definitively linked it to a human disease. This paper is the bridge. So who provided that proof? The study centers on 17 individuals from 7 families?
4:21And looking at the demographics, I see a pattern here. You mean the consanguinity? Right. Most of these families were from the Middle East or Southeast Asia, Egypt, Saudi Arabia, Iran, and the parents were often related, 1st cousins usually.
4:36And that's so important for finding these rare recessive diseases. Can you just quickly explain why that is? Sure. So we all carry broken jeans, you, me, everyone, but usually we have a 2nd working copy from our other parent to, you know, pick up the slack.
4:50A backup copy. Exactly. In consanguineous families, there's a much higher chance that bull parents carry the exact same rare mutation from a common ancestor. So instead of getting one good copy and one bad one.
5:00The child gets 2 bad copies, no backup. And that's what we call homozygus. And the consequences here were, well, they were grim. The paper reports that 8 of the 17 individuals passed away. It just underscores that lethality you saw in the mice.
5:16This is a system critical failure. absolutely is. Okay, so walk me through the detective work. How did they find MDGA 2 in the 1st place? They used XM sequencing. So they're looking just at the parts of the DNA, that code for proteins.
5:30Right. It's only about one% of the genome, but it's where about 85% of known disease causing mutations are found. They sequence these families and we're looking for one specific thing. Those homazygus variants.
5:42The spots where both copies of the gene were broken. And in all these families, the signal pointed straight to MDGA 2. And these weren't subtle changes, right? Oh, not at all. These were catastrophic errors.
5:53They found nonsense variants, which are basically premature stop signs in the code. It just chops the protein in half. Right, or frame shifts, which scramble the whole recipe. The prediction was clear, loss of function.
6:04The gene was essentially off. But a prediction isn't proof in science. No, it is not. And this is where the paper gets really elegant. Then you just stop at the genetics. They went to the bench to prove the mechanism.
6:15The validation. The gold standard, they used standard human cell lines and cultured rat neurons to create a disease in a dish. They put the specific patient mutations into these cells and watch what happened.
6:30Okay, I want to get to that mechanism in a 2nd because that's the aha moment. But first, let's make the clinical picture. What does a child with this condition actually look like? The phenotype, the set of observable traits, was remarkably consistent.
6:44The 1st thing you'd see is severe infantile hypotonia. Floppy baby syndrome. Yes, very low muscle tone. Then, global developmental delay. Many of these children never learn to walk independently or to speak in any significant way.
6:57And the seizures. Intractable. And they start very early. It's just a storm from the beginning, but they're also physical markers. You mean the dysmorphic features? Exactly. A tented upper lip, broad nasal bridge, high hairline, and large, low set ears.
7:11And the paper notes these features became more pronounced with age. It's like the physical form is mirroring the developmental derailment. What about inside the brain, the MRI scans? The imaging was stark.
7:23It showed early onset brain atrophy. The brain was physically shrinking. Wow. They also saw thinning white matter and delayed myelination. Milan is the insulation on the wires. Right. And in these kids, that insulation wasn't forming properly.
7:36So you've got a shrinking brain with uninsulated wires. It's a devastating picture. Okay, so let's get to that aha moment. The core insight. It brings us back to the car. To understand the break, we have to meet the gas pedal.
7:48Let's talk about Neuraligion one. Okay, so Neurlegend one or NLGN one. In the brain, this protein is, it's like an aggressive contractor. Its job is to build excitatory synapses. It's constantly screaming, let's connect, let's fire.
8:03That's a perfect description. It wants to maximize connectivity all the time. So neurology one is the gas pedal pushed to the floor. Exactly. And normally our gene, MDGA 2 is the brake. It's the zoning board, or maybe the bouncer at the club, MDGA 2 physically binds to neurology in one.
8:19It covers it up. It blocks it. It blocks it from interacting with this partner in Erexon. It basically says, no, we don't need a synapse here. Calm down. It suppresses those excitatory connections. So in these patients, where MDGA 2 is broken.
8:33The bouncer is gone. But it's actually more specific. Their lab studies show that the mutated MDGA 2 proteins were still being made, but they had a trafficking failure. What's trafficking failure? Well, proteins are built deep inside the cell, but they have to travel to the surface membrane to do their job.
8:49These mutated proteins. They got stuck. were stuck in the locker room. Exactly. The bouncer is locked in the back room, and the door to the club is wide open. Neurology one is completely unchecked. It just starts building bridges everywhere.
9:02The result is a massive, unregulated increase in excitatory synapses. The brain becomes hyperconnected. And hyperconnected is not a good thing. No, it's chaos. It tips that EI balance violently toward excitation.
9:16They actually prove this with electrophysiology, right? They measured the electrical current. They did. They looked at something called miniature excitatory postsynaptic currents, or MEPSEs, and the frequency was just, it was way off.
9:30The neurons were screaming when they should have been whispering. That is such a clear mechanism. It's not just something went wrong. It's specifically, the suppressor of the builder failed. So the builder went rogue.
9:40Ah, and that specificity is what makes this a breakthrough. It confirms this idea that epilepsy is often a disease of synaptic biology. It's not just about the channels. It's about the architecture. Too many roads, not enough stop signs.
9:53For the families, this diagnosis is huge. It ends the odyssey, but the next question is always, can we fix it? The hardest question. But the paper does offer a few glimmers of hope. I saw something fascinating in the clinical notes about 2 patients, P4 and P5B.
10:10know exactly what you're looking at. The ketogenic diet. We hear keto and think of, you know, weight loss fads, but this is its original medical purpose. 100%. The keto diet was developed in the 1920s, specifically for epilepsy.
10:22It forces the brain to switch its fuel source from glucose to ketones. And for these two kids with this specific broken gene, it actually helped. It offered partial seizure control. No, it wasn't a cure, let's be very clear, but it did dampen the storm.
10:37That's incredible. You have this hardwired genetic defect, too many synapses, and yet changing the brain's fuel source helped. How? That's the $1000000 question. We think ketosis modulates neurotransmitters.
10:51It tends to increase inhibition GABA and decrease excitation glutamate. So even though the physical brakes are missing, the diet might be tweaking the chemistry to achieve a similar effect. It's a workaround is bypassing the genetics.
11:04To an extent, yes. It's a hint that even with a structural flaw, there's still plasticity, you can tweak the software even if the hardware is damaged. Did they point to any drug targets? Can we attack this mechanism more directly?
11:16They did, based on the mouse data? The thinking is, if you can't fix the overproduction of excitatory signals, maybe you can block their reception. They suggested inhibiting a receptor called TRKB or blocking MPR signaling.
11:29And APR receptors are the ones that catch the excitatory signals, right? Exactly. If you can't stop the pitcher, maybe you can take the glove away from the catcher. If you block the reception, you might restore some balance.
11:40That's a targeted approach you could only dream of without knowing the gene. Right. It moves us from just guessing towards precision medicine. We should mention the limitations, though. What couldn't they do here?
11:52The big one was tissue availability. MDGA 2 expression is very low in accessible tissues like blood or skin. So you can't just take a blood draw and see the protein failing. No. That's why they had to rely on the cell lines and the rat neurons.
12:08It's a very robust model, but it's still a model. And the next step would be IPSEs. Induced pluropotent stem cells. Yeah. You take a patient's own skin cells, turn them back into stem cells, and then grow them into human neurons in a dish.
12:22So you're basically growing a tiny model of the patient's own brain. In essence, yes. And that would let you test these potential drug targets on the patient's actual cells. That's the future. So if we pull back to the 30,000 foot view.
12:36What's the take on message here? The headline is that we have a new definitive cause for a severe DE, homozygous loss of function in MBGA2. But the deeper insight, I think, is about the brain's precarious balance.
12:49This gene teaches us that the brain needs active, constant suppression to work properly. Without the no signal from MDGA 2, the system just collapses into chaos. It redefines epilepsy not just as a firing problem, but as a breaking problem.
13:04A braking problem. Exactly. That brings me to a thought I've been mulling over since reading that section on the diet. We think of genetic diseases as these fixed sentences, you know, your DNA is your destiny.
13:15But here, a metabolic shift changing what the patient ate actually altered the outcome of this profound genetic break. It makes me wonder, are we underestimating the power of metabolism to bypass our own genetic wiring?
13:28That's a fascinating question. Could we treat other incurable genetic neurological disorders, not with high-tech gene editing, but with precision nutrition, by figuring out the specific metabolic needs of a specific genetic error?
13:40That's a really provocative thought. We're always chasing the high-tech solution like CRISPR. But the brain is an energy hungry organ. Maybe if we can stabilize the energy supply. We can stabilize the network, even when the wiring itself is faulty.
13:56It suggests the software might be able to patch the hardware. Something to chew on. This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description.
14:10If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating. If you'd like to support our work, use the donation link in the description. Now stay with us for an original track created especially for this episode, and inspired by the article you've just heard about.
14:24Thanks for listening, and join us next time as we explore more science base by base.
